Giselle Lynch and Evan Wiley were among 25 students at Icahn School of Medicine at Mount Sinai who enrolled in a new elective course last spring that challenged them to explore their personal biases while teaching them about race as a social determinant of health.
In November, Elizabeth Adler (class of 2016) became the first student at Icahn School of Medicine at Mount Sinai to receive an Excellence in LGBT Health and Advocacy Scholarship. The $10,000 award is believed to be the first of its kind in the nation. It underscores the Mount Sinai Health System’s commitment to ensuring high-quality medical care for the lesbian, gay, bisexual, and transgender (LGBT) community, with its diverse set of health needs.
A physician-scientist and a clinical investigator at the James J. Peters VA Medical Center in the Bronx were presented with the 2014 Samuel J. Heyman Service to America Medal in Science and the Environment for their groundbreaking contributions to improving the health care and quality of life of paralyzed veterans. The ceremony took place on Monday, September 22, in Washington, D.C.
Icahn School of Medicine at Mount Sinai’s 29th annual Convocation Ceremony, held Monday, September 29, honored 10 physician-scientists whose groundbreaking achievements have made them leaders in the fields of cancer, HIV/AIDs, immunology, microbiology, ophthalmology, psychiatry, rheumatology, surgery, and urology.
Amid much jubilation, 140 first-year students at Icahn School of Medicine at Mount Sinai symbolically marked the start of their medical education by receiving white coats and stethoscopes at the 17th Annual White Coat Ceremony held Monday, September 8.
“Some members of the Class of 2018 will make scientific discoveries that will improve our ability to diagnose and treat patients, while others will become master clinicians and educators, or focus on improving public health for underserved communities around the world,” Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai and President for Academic Affairs, Mount Sinai Health System, told the students. “The medical path you choose must be powered by idealism. We will nurture your idealism—because at Mount Sinai we translate idealism into action for the betterment of patients everywhere.”
The Icahn School of Medicine at Mount Sinai has teamed up with Wiley to create a series of expert guides for medical trainees. The Mount Sinai Expert Guides series combine the expertise of our faculty with new online platforms and mobile apps.
The first title in the series, Mount Sinai Expert Guides: Hepatology, is now available in print and digital formats. Additional online material includes video clips, case studies, interactive multiple choice questions, and patient advice. In the coming months, five more Mount Sinai Expert Guides will be published on Gastroenterology, Cardiology, Allergy and Clinical Immunology, Neurology, and Psychiatry.
The opportunity to reduce health care costs without compromising quality makes this an exciting time to be a leader in the field of health care delivery, says Peter R. Orszag, PhD, Vice Chairman of Corporate and Investment Banking, Chairman of the Public Sector Group, and Chairman of the Financial Strategy and Solutions Group at Citigroup, Inc.
Dr. Orszag, a member of the Mount Sinai Health System Boards of Trustees, shared this encouraging message during a conference on Tuesday, August 26, to kick off Icahn School of Medicine at Mount Sinai’s new Master of Science in Health Care Delivery Leadership program. Classes for the first year of the program started during the final week of August.
Fifteen high school, college, and graduate students who aspire to careers in the field of health care, participated this summer in internships throughout the Mount Sinai Health System, in areas such as medical records, managed care, ambulatory care, scientific research, and real estate services.
On July 29, 2014, Thomson Reuters awarded an Impact Factor of 5.486 to the open access journal Molecular Autism. This represents the highest Impact Factor for any journal dedicated to autism or related neurodevelopmental conditions.
The journal was created in 2010, by Professor Joseph Buxbaum, Director of the Seaver Autism Center and Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, and Professor Simon Baron-Cohen, Director of the Autism Research Centre at the University of Cambridge. The goal of the journal was to provide an outlet for the volume of exciting genetic and other molecular autism research papers, and to make this cutting-edge autism research available freely via open access. In the past four years, Molecular Autism has grown and now publishes approximately five articles per month.